MENU

Why the G Medical Innovations Holdings Ltd share price is falling today

Shares in G Medical Innovations Holdings Ltd (ASX: GMV) are down 5 per cent to 50 cents in trade today after the group returned to the ASX boards following a $13.5 million capital raising.

G Medical Innovations operates in the digital and mobile health medical device space and issued 31.4 million new shares at 43 cents per share to sophisticated and institutional investors.

The business only listed in May 2017 and reports that it has already received U.S. FDA (regulatory) approval for its Prizma Smartphone Case.

According to the company the smartphone case has a variety of sensors that can help a user record their vital signs such as temperature, stress levels, or heart rate. After which the data can be stored online via a mobile app.

The company also reports it has developed a G Medical Patch (GMP) that also helps users measure vital signs to assist in diagnosing medical problems remotely.

Unfortunately, the company posted nothing in the way of revenues for the quarter ending September 30 2017 in delivering an operating cash outflow of $1.94 million for the quarter. However, after its recent capital raising it does reportedly have cash on hand of around $22.9 million to fund its commercialisation initiatives.

Given the lack of revenues it looks a speculative bet with plenty of risk to the downside.

Why Elon Musk's "secret weapon" was the most shorted share in Australia...

On 9 March, the visionary Tesla co-founder and CEO made a bold $63,000,000 to save a large swath of Australia. But in the process, he accidentally revealed the small Melbourne-based company that allows him to consistently make the impossible possible. At one point, this little understood company was actually the single most heavily shorted share in all of the ASX. Yet oddly enough, nine out of 10 analysts call it a screaming BUY! And that includes Motley Fool Australia.

We just isolated this company as Elon Musk's "secret weapon", and think it's dynamic run (up more than double after initially floating shares just two and a half years ago!) is only getting started. For the full story on this company, as well as how to get invested alongside us today, simply click here!

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.